Anthracycline-mediated cardiac dysfunction: An endothelial perspective
This study reveals that while anthracycline-induced endothelial injury largely resolves after childhood cancer treatment, long-term cardiovascular risk is driven by impaired endothelial repair mechanisms characterized by depleted and senescent endothelial progenitor cells during remission.